World News
-
US team develops tool to identify disease-carrying mosquitoes
World | News | 0 Comment | 04 Sep, 2018
A team of researchers at the University of Texas has developed a new diagnostic tool to identify a species of mosquito t...Read more
-
Global orphan dermatology products market to beat $6B by 2024
World | News | 0 Comment | 03 Sep, 2018
The global orphan and rare dermatology premium products market is expected to grow rapidly from $1.64 billion in 2017 to...Read more
-
Sartorius sets up Life Science Factory for startup entrepreneurs
World | News | 0 Comment | 31 Aug, 2018
With its newly founded, independent Life Science Factory, Sartorius, a leading international partner of the biopharmaceu...Read more
-
TB Alliance Launches Clinical Trial for New TB drug
World | News | 0 Comment | 31 Aug, 2018
TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight...Read more
-
Roche to create industry-ready graduates
World | News | 0 Comment | 30 Aug, 2018
Roche Diagnostics and the University of Indianapolis are partnering to create a custom talent pipeline for biomedical eq...Read more
-
World | News | 0 Comment | 30 Aug, 2018
SOTIO, a biotechnology company owned by the PPF Group, announces today the completion of the acquisition of Cytune Pharm...Read more
-
ImaginAb, CPDC enter into an agreement
World | News | 0 Comment | 30 Aug, 2018
ImaginAb, Inc., an immuno-oncology imaging company, and Centre for Probe Development and Commercialization (CPDC), a Can...Read more
-
Are you Ready for EU FMD? Urgency, Consistency and Planning are Key
World | News | By Vikash Pushpraj, SVP, rfxcel | 0 Comment | 29 Aug, 2018
Singapore - In February 2019, the Delegated Regulation to the Falsified Medicines Directive (FMD) comes legally into for...Read more
-
CytoDyn signs definitive agreement to acquire Prostagene
World | News | 0 Comment | 28 Aug, 2018
Singapore – CytoDyn, a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple th...Read more
-
Urovant licenses novel gene therapy for overactive bladder
World | News | 0 Comment | 28 Aug, 2018
Singapore - Urovant Sciences, a clinical-stage biopharmaceutical company focused on developing therapies for urologic co...Read more
-
Patrys, Walter and Eliza Hall awarded grant
World | News | 0 Comment | 28 Aug, 2018
Singapore - Patrys Limited and the Walter and Eliza Hall Institute of Medical Research have recently been awarded a...Read more
-
Eisai announces long-term cardiovascular outcomes data for anti-obesity Agent
World | News | 0 Comment | 28 Aug, 2018
Eisai Inc. recently announced that results from the CAMELLIA-TIMI 61 cardiovascular (CV) outcomes trial in patients trea...Read more
-
Study reveals reasons of death after non-cardiac surgery
World | News | 0 Comment | 28 Aug, 2018
The main reasons why people die after non-cardiac surgery are revealed in a study of more than 40,000 patients from six ...Read more
-
Researchers find new blood clot prevention strategy
World | News | 0 Comment | 27 Aug, 2018
Feinstein Institute for Medical Research Professor Alex C. Spyropoulos, MD, has uncovered an anticoagulant treatment str...Read more
-
BHF launches £30 M funding for cardiovascular research
World | News | 0 Comment | 27 Aug, 2018
The British Heart Foundation (BHF) has launched the Big Beat Challenge, a unique research funding award that will bring ...Read more
-
Shire receives USFDA nod for TAKHZYRO
World | News | 0 Comment | 27 Aug, 2018
Shire, the leading global biotechnology company focused on rare diseases, has announced that following priority review, ...Read more
-
GT Biopharma appoints David Cardino as VP, Finance
World | News | 0 Comment | 24 Aug, 2018
GT Biopharma Inc. (GTBP) an immuno-oncology biotechnology company focused on innovative treatments based on the company'...Read more
-
Facebook, NYU to initiate fastMRI using AI
World | News | 0 Comment | 24 Aug, 2018
Facebook has partnered with New York University (NYU) School of Medicine to initiate a research project focused on lever...Read more
